SCHEMBL10412088

SCHEMBL10412088

COc1ccc(CCc2ccc(NC(=O)C(=O)c3sc4ccccc4c3O)cc2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.56
▸ LMNA P02545 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ THRB P10828 1/20 0.47
▸ POLB P06746 2/20 0.46
▸ CNR1 P21554 1/20 0.45
▸ NAMPT P43490 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ F10 P00742 1/20 0.43
▸ MAOB P27338 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ PLAAT3 P53816 1/20 0.42
▸ PLAAT5 Q96KN8 1/20 0.42
▸ PLAAT2 Q9NWW9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10412027 0.84 ALOX15 (0.54) MAPTF10MAOB
SCHEMBL10411951 0.78 ATM (0.53) MAPTLMNATHRBPOLBNAMPT
SCHEMBL9826567 0.78 THRB (0.54) MAPTGAATHRBPOLBCNR1
SCHEMBL10384541 0.76 ALOX15 (0.56) LMNATHRBPOLBCNR1ALDH1A1
SCHEMBL10483343 0.74 THRB (0.63) MAPTLMNATHRBPOLBCNR1
SCHEMBL10411288 0.74 MAPT (0.47) MAPTLMNATHRBPOLBCNR1
SCHEMBL9826852 0.73 CNR1 (0.56) MAPTLMNAGAATHRBPOLB
SCHEMBL9828478 0.73 THRB (0.48) MAPTLMNATHRBPOLBCNR1
SCHEMBL12204218 0.72 MAPT (1.00) MAPTLMNAGAANAMPTALDH1A1
SCHEMBL10768004 0.72 ALOX15 (0.55) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4761424-A Enolamides, pharmaceutical compositions and methods for treating inflammation WARNER-LAMBERT COMPANY (US) 1988-08-02 — — US claimed
EP-0221345-A1 Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1987-05-13 — — EP claimed
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US disclosed
US-4874758-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-10-17 — — US disclosed
US-4868195-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868205-A ANTIALLERGENS, ANTIINFLAMMATORY, CARDIOVASCULAR DISORDERS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868200-A LEUKOTRIENES, LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868199-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4761424-A Enolamides, pharmaceutical compositions and methods for treating inflammation WARNER-LAMBERT COMPANY (US) 1988-08-02 — — US disclosed
EP-0221345-A1 Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1987-05-13 — — EP disclosed
Send feedback